Summary: Host‐guest complexes of styrene and randomly methylated β‐cyclodextrin (m‐β‐CD) were polymerized in aqueous medium via the reversible addition fragmentation chain transfer (RAFT) process. 3‐Benzylsulfanylthiocarbonylsulfanylpropionic acid (TTC) was used as trithiocarbonate‐type RAFT agent. The results indicate a controlled character of the polymerization of the styrene complexes as the number‐average molecular weight, $\overline M _{\rm n}$, increases linearly with monomer to polymer conversion; however, the molecular weights of the obtained polystyrenes deviate to higher values than those theoretically predicted. Nevertheless, the molecular weights can be controlled by variation of the initial RAFT agent concentration. The polystyrenes produced in this system exhibited narrower polydispersities (1.23 < $\overline M _{\rm w} /\overline M _{\rm n}$ < 2.36) than those produced without RAFT agent (5.24 < $\overline M _{\rm w} /\overline M _{\rm n}$ < 9.21) under similar conditions. The present contribution represents the first example of RAFT polymerization of a m‐β‐CD‐complexed hydrophobic vinylmonomer (styrene) from homogenous aqueous solution.Schematic presentation of complexation and RAFT polymerization of m‐β‐CD‐complexed styrene with TTC as RAFT agent and evolution of the full molecular weight distributions in the CD‐mediated styrene free radical RAFT polymerization.imageSchematic presentation of complexation and RAFT polymerization of m‐β‐CD‐complexed styrene with TTC as RAFT agent and evolution of the full molecular weight distributions in the CD‐mediated styrene free radical RAFT polymerization.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.